Gardasil 9 syringe 0.5ML

Ended Awarded Last action

Contract number
SPE2DR26F7PSB
Awardee
Awarding agency
Obligated
$22,681

Award facts

Contract value 100% obligated
$22,680.52 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $22,680.52 delivery order to AmerisourceBergen Drug Corp on February 18, 2026, for Gardasil 9 vaccine in 0.5 mL syringe configuration.

The order is placed under the DLA Troop Support Medical Indefinite Delivery Contract (valued at $999,999,999.00 through December 2026), which supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order has a firm fixed price structure with an ultimate completion date of February 19, 2026.

Quick answers

Who was awarded contract SPE2DR26F7PSB?

SPE2DR26F7PSB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 18, 2026.

How much is contract SPE2DR26F7PSB worth?

The government has obligated $22,681 on SPE2DR26F7PSB.

Is contract SPE2DR26F7PSB an order under another contract?

Yes. SPE2DR26F7PSB is a delivery order under SPE2DR25D7059, an indefinite delivery contract.

Was contract SPE2DR26F7PSB competed?

The extent of competition for SPE2DR26F7PSB was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award